GRWG
GrowGeneration Corp.
GRWG has a slight edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
GRWG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
GRWG's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GRWG PE Valuation
GRWG has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GRWG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect GRWG's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GRWG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.23 | +$0.44 |
| Q2 2026 | -$0.27 | +$0.55 |
| Q1 2026 | -$0.32 | +$0.52 |
| Q4 2025 | -$0.40 | +$0.42 |
| Q3 2025 | -$0.67 | +$0.21 |
| Q2 2025 | -$0.82 | -$0.01 |
| Q1 2025 | -$0.84 | -$0.04 |
| Q4 2024 | -$0.82 | -$0.06 |
GRWG is still losing money, but far less than before: $0.23 per share over the past year, against $2.70 at its worst in early 2023.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GRWG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $44.8M | -5.2% |
| Q2 2026 | $43.2M | +5.5% |
| Q1 2026 | $38.4M | +7.5% |
| Q4 2025 | $37.8M | +1% |
| Q3 2025 | $47.3M | -5.5% |
| Q2 2025 | $41M | -23% |
| Q1 2025 | $35.7M | -25% |
| Q4 2024 | $37.4M | -24% |
GRWG's revenue fell from its 2021 peak and has held roughly level since: $45M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.1% | +5.9 points |
| Q2 2026 | -5.4% | +7.5 points |
| Q1 2026 | -14% | +14 points |
| Q4 2025 | -20% | +44 points |
| Q3 2025 | -6% | +18 points |
| Q2 2025 | -13% | -0.7 points |
| Q1 2025 | -28% | -8 points |
| Q4 2024 | -64% | -8.9 points |
GRWG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GRWG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GRWG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $555K | +$1.1M |
| Q2 2026 | $941K | +$3.9M |
| Q1 2026 | -$5M | -$1.2M |
| Q4 2025 | -$2.2M | -305% |
| Q3 2025 | -$499K | -143% |
| Q2 2025 | -$2.9M | -$2.6M |
| Q1 2025 | -$3.8M | -$153K |
| Q4 2024 | $1.1M | +$2.4M |
GRWG has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GRWG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -550K shares |
| 1 year | -0.9% | -528K shares |
| 3 years | -3.3% | -2M shares |
| 5 years | -0.4% | -235K shares |
| Available history | +51% | +20M shares |
GRWG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | $1,000 |
| Q3 2024 | $1.8M |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | $4M |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
GRWG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -3.1x | Net Cash |
| Q4 2021 | -1.5x | Net Cash |
| Q3 2021 | -1.8x | Net Cash |
| Q2 2021 | -2.1x | Net Cash |
| Q1 2021 | -4.1x | Net Cash |
| Q4 2020 | -16.3x | Net Cash |
| Q3 2020 | -7.8x | Net Cash |
| Q2 2020 | -5.0x | Net Cash |
GRWG has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GRWG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 18.6 | Oversold |
GRWG's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GRWG PE vs Consumer Cyclical Sector
| Metric | GRWG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GRWG has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GRWG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.46 | 16% below |
| 20 week MA | $1.51 | 19% below |
| 50 week MA | $1.44 | 15% below |
| 100 week MA | $1.39 | 12% below |
| 200 week MA | $2.08 | 41% below |
GRWG is in a downtrend: it's below all five of its weekly moving averages, and 41% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GRWG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.23 | $41.3 | +876% |
| 2021 | $41.3 | $13.6 | -67% |
| 2022 | $13.6 | $4.26 | -69% |
| 2023 | $4.26 | $2.51 | -41% |
| 2024 | $2.51 | $1.54 | -39% |
| 2025 | $1.54 | $1.61 | +4.5% |
| 2026 YTD | $1.61 | $1.23 | -24% |
GRWG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.